MedTrace Logo

Panda: Evaluation of a Smartphone-based Perioperative Pain Assessment Tool

NCT01610882 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2017-10-26

No results posted yet for this study

Summary

This study will evaluate Panda, a smartphone-based pain assessment tool. During a child's recovery from surgery, a Post-Anesthetic Care Unit nurse will assess their pain, which helps determine what medication they need. Traditionally, this involves asking the child to rate their pain on a scale from 1 to 10, by moving a slider along a coloured scale or pointing to one of a series of faces on a piece of card. The Panda uses the same methods, but presents them on a smartphone screen. Our evaluation will ensure that the Panda gives the same pain scores as the traditional methods.

Conditions

  • Acute Post-operative Pain

Interventions

DEVICE

Panda first followed by manual pain assessment

Panda is a smart-phone based application designed to assess post-operative pain; manual method involves use of CAS/FPS-R on paper. Panda will be used first, manual method 5 mins later.

DEVICE

Manual first followed by Panda pain assessment

Panda is a smart-phone based application designed to assess post-operative pain; manual method involves use of CAS/FPS-R on paper. Manual method will be used first, Panda 5 mins later.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Mark Ansermino · UBC/Medicine, Faculty of/Anesthesiology, Pharmacology & Therapeutics

  • Gillian Lauder · UBC/Medicine, Faculty of/Anesthesiology, Pharmacology & Therapeutics

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01610882 on ClinicalTrials.gov